S5561 Chronic Budd-Chiari Syndrome as Unique Presentation of Multi-Organ Sarcoidosis

Introduction: Sarcoidosis is a systemic granulomatous disease of unknown etiology. Hepatic involvement occurs in 50%-65% of patients with sarcoidosis, although symptoms occur in only 5%-15%. Rare case reports suggest that sarcoidosis may cause Budd Chiari syndrome. Here, we present a case of multi-organ sarcoidosis presenting as chronic Budd Chiari syndrome. Case Description/Methods: A 69-year-old African-American man with no past medical history presented with dyspnea. He was found to have a hydropneumothorax along with liver injury of aspartate aminotransferase 110, alanine aminotransferase 67, total bilirubin 3.2, alkaline phosphatase 271, and international normalized ratio 1.5. He reported 1 alcoholic drink monthly. He underwent serologic work-up, liver imaging, and liver biopsy to determine etiology of liver injury. Serologic work-up revealed strongly positive ANA with titer 1:2,560, IgG level elevated to 3,190, and IgA level elevated to 1,470. Computed tomography (CT) abdomen pelvis with contrast revealed cirrhotic liver morphology with dilated splenic varices and small volume ascites fluid. Magnetic resonance imaging (MRI) abdomen with and without contrast revealed chronic thrombosis of the intrahepatic and main portal veins and hepatic veins suggestive of chronic Budd Chiari syndrome. Liver histology revealed mild to moderate portal chronic inflammation with well-formed granulomas, portal fibrosis, and patchy sinusoidal dilation consistent with hepatic sarcoidosis. No cirrhosis was seen on biopsy. Stains for fungi and acid fast bacilli were negative. His course was complicated by hypotension, bradycardia, and acute hypoxic respiratory failure. Right heart catheterization was consistent with mild pre-capillary pulmonary hypertension. CT chest revealed bilateral central predominant architectural distortion and traction bronchiectasis consistent with pulmonary sarcoidosis. MRI brain revealed irregular pachymeningeal thickening in right frontoparietal high convexity indicative of neurosarcoidosis. Discussion: Multisystem sarcoidosis was concluded to be the unifying diagnosis. He was started on infliximab and prednisone. His liver enzymes down-trended and he was discharged on a prednisone taper. Budd Chiari syndrome is a rare complication of hepatic sarcoidosis. The pathogenesis consists of granulomatous inflammation leading to venous thrombosis and obstruction. In the setting of Budd Chiari syndrome without clear etiology, sarcoidosis should be considered. Prompt recognition and treatment of multisystem sarcoidosis with glucocorticoids and immunosuppressive agents is important to prevent irreversible organ damage.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001149704.83309.ea
Primary Topic
Sarcoidosis and Beryllium Toxicity Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S5561 Chronic Budd-Chiari Syndrome as Unique Presentation of Multi-Organ Sarcoidosis

Ugochukwu Akpara, A. Diehl, Reeti Gulati
The American Journal of Gastroenterology
Sarcoidosis and Beryllium Toxicity Research
article

S5561 Chronic Budd-Chiari Syndrome as Unique Presentation of Multi-Organ Sarcoidosis

Ugochukwu Akpara, A. Diehl, Reeti Gulati
article en

Abstract

Introduction: Sarcoidosis is a systemic granulomatous disease of unknown etiology. Hepatic involvement occurs in 50%-65% of patients with sarcoidosis, although symptoms occur in only 5%-15%. Rare case reports suggest that sarcoidosis may cause Budd Chiari syndrome. Here, we present a case of multi-organ sarcoidosis presenting as chronic Budd Chiari syndrome. Case Description/Methods: A 69-year-old African-American man with no past medical history presented with dyspnea. He was found to have a hydropneumothorax along with liver injury of aspartate aminotransferase 110, alanine aminotransferase 67, total bilirubin 3.2, alkaline phosphatase 271, and international normalized ratio 1.5. He reported 1 alcoholic drink monthly. He underwent serologic work-up, liver imaging, and liver biopsy to determine etiology of liver injury. Serologic work-up revealed strongly positive ANA with titer 1:2,560, IgG level elevated to 3,190, and IgA level elevated to 1,470. Computed tomography (CT) abdomen pelvis with contrast revealed cirrhotic liver morphology with dilated splenic varices and small volume ascites fluid. Magnetic resonance imaging (MRI) abdomen with and without contrast revealed chronic thrombosis of the intrahepatic and main portal veins and hepatic veins suggestive of chronic Budd Chiari syndrome. Liver histology revealed mild to moderate portal chronic inflammation with well-formed granulomas, portal fibrosis, and patchy sinusoidal dilation consistent with hepatic sarcoidosis. No cirrhosis was seen on biopsy. Stains for fungi and acid fast bacilli were negative. His course was complicated by hypotension, bradycardia, and acute hypoxic respiratory failure. Right heart catheterization was consistent with mild pre-capillary pulmonary hypertension. CT chest revealed bilateral central predominant architectural distortion and traction bronchiectasis consistent with pulmonary sarcoidosis. MRI brain revealed irregular pachymeningeal thickening in right frontoparietal high convexity indicative of neurosarcoidosis. Discussion: Multisystem sarcoidosis was concluded to be the unifying diagnosis. He was started on infliximab and prednisone. His liver enzymes down-trended and he was discharged on a prednisone taper. Budd Chiari syndrome is a rare complication of hepatic sarcoidosis. The pathogenesis consists of granulomatous inflammation leading to venous thrombosis and obstruction. In the setting of Budd Chiari syndrome without clear etiology, sarcoidosis should be considered. Prompt recognition and treatment of multisystem sarcoidosis with glucocorticoids and immunosuppressive agents is important to prevent irreversible organ damage.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 51%
Sarcoidosis and Beryllium Toxicity Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.